The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Computational Modeling of β-Secretase 1 (BACE-1) Inhibitors Using Ligand Based Approaches
Abstract
The binding affinities (IC 50 ) reported for diverse structural and chemical classes of human β-secretase 1 (BACE-1) inhibitors in literature were modeled using multiple in silico ligand based modeling approaches and statistical techniques. The descriptor space encompasses simple binary molecular fingerprint, one- and two-dimensional constitutional, physicochemical, and topological descriptors, and sophisticated three-dimensional molecular fields that require appropriate structural alignments of varied chemical scaffolds in one universal chemical space. The affinities were modeled using qualitative classification or quantitative regression schemes involving linear, nonlinear, and deep neural network (DNN) machine-learning methods used in the scientific literature for quantitative–structure activity relationships (QSAR). In a departure from tradition, ∼20% of the chemically diverse data set (205 compounds) was used to train the model with the remaining ∼80% of the structural and chemical analogs used as part of an external validation (1273 compounds) and prospective test (69 compounds) sets respectively to ascertain the model performance. The machine-learning methods investigated herein performed well in both the qualitative classification (∼70% accuracy) and quantitative IC 50 predictions (RMSE ∼ 1 log). The success of the 2D descriptor based machine learning approach when compared against the 3D field based technique pursued for h BACE-1 inhibitors provides a strong impetus for systematically applying such methods during the lead identification and optimization efforts for other protein families as well.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2014) · Cited by 33,419
Kohonen, T. (2001) · Springer Series in Information Sciences · doi:10.1007/978-3-642-56927-2 · Cited by 16,019
Extended-Connectivity Fingerprints
Rogers, D., & Hahn, M. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100050t · Cited by 7,524
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Docking and scoring in virtual screening for drug discovery: methods and applications
Kitchen, D. B., Decornez, H., Furr, J. R., & Bajorath, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1549 · Cited by 4,150
Cramer, R. D., Patterson, D. E., & Bunce, J. D. (1988) · Journal of the American Chemical Society · doi:10.1021/ja00226a005 · Cited by 3,931
The Properties of Known Drugs. 1. Molecular Frameworks
Bemis, G. W., & Murcko, M. A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9602928 · Cited by 2,482
A geometric approach to macromolecule-ligand interactions
Kuntz, I. D., Blaney, J. M., Oatley, S. J., Langridge, R., & Ferrin, T. E. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90153-x · Cited by 2,278
Chou, P. Y., & Fasman, G. D. (1974) · Biochemistry · doi:10.1021/bi00699a001 · Cited by 2,172
QSAR Modeling: Where have you been? Where are you going to?
Cherkasov, A., Muratov, E. N., Fourches, D., Varnek, A., Baskin, I. I., Cronin, M., Dearden, J., Gramatica, P., Martin, Y. C., Todeschini, R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4004285 · Cited by 2,164
Computational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
A Critical Assessment of Docking Programs and Scoring Functions
Warren, G. L., Andrews, C. W., Capelli, A.-M., Clarke, B., LaLonde, J., Lambert, M. H., Lindvall, M., Nevins, N., Semus, S. F., Senger, S., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050362n · Cited by 1,814
DataWarrior: An Open-Source Program For Chemistry Aware Data Visualization And Analysis
Sander, T., Freyss, J., von Korff, M., & Rufener, C. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500588j · Cited by 1,800
Alzheimer’s disease drug-development pipeline: Few candidates, frequent failures
Cummings, J. L., Morstorf, T., & Zhong, K. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt269 · Cited by 1,744
JPred4: a protein secondary structure prediction server
Drozdetskiy, A., Cole, C., Procter, J., & Barton, G. J. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv332 · Cited by 1,744
Wang, L., Wu, Y., Deng, Y., Kim, B., Pierce, L., Krilov, G., Lupyan, D., Robinson, S., Dahlgren, M. K., Greenwood, J., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/ja512751q · Cited by 1,313
Role of Molecular Dynamics and Related Methods in Drug Discovery
De Vivo, M., Masetti, M., Bottegoni, G., & Cavalli, A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01684 · Cited by 1,297
HANSCH, C., MALONEY, P. P., FUJITA, T., & MUIR, R. M. (1962) · Nature · doi:10.1038/194178b0 · Cited by 1,056
The Process of Structure-Based Drug Design
Anderson, A. C. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.09.002 · Cited by 939
Role of computer-aided drug design in modern drug discovery
Macalino, S. J. Y., Gosu, V., Hong, S., & Choi, S. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0640-5 · Cited by 762
Deep Learning in Drug Discovery
Gawehn, E., Hiss, J. A., & Schneider, G. (2016) · Molecular Informatics · doi:10.1002/minf.201501008 · Cited by 723
Structure of the Protease Domain of Memapsin 2 (β-Secretase) Complexed with Inhibitor
Hong, L., Koelsch, G., Lin, X., Wu, S., Terzyan, S., Ghosh, A. K., Zhang, X. C., & Tang, J. (2000) · Science · doi:10.1126/science.290.5489.150 · Cited by 711
In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
Ekins, S., Mestres, J., & Testa, B. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707305 · Cited by 703
Applications of Deep Learning in Biomedicine
Mamoshina, P., Vieira, A., Lane, E., & Zhavoronkov, A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00982 · Cited by 701
Ligand efficiency indices as guideposts for drug discovery
Abad-Zapatero, C., & Metz, J. T. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03386-6 · Cited by 527
Practical Aspects of Free-Energy Calculations: A Review
Hansen, N., & van Gunsteren, W. F. (2014) · Journal of Chemical Theory and Computation · doi:10.1021/ct500161f · Cited by 383
Deep Learning for Drug-Induced Liver Injury
Xu, Y., Dai, Z., Chen, F., Gao, S., Pei, J., & Lai, L. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00238 · Cited by 382
Massively Multitask Networks for Drug Discovery
Ramsundar, B., Kearnes, S. M., Riley, P., Webster, D. R., Konerding, D. E., & Pande, V. S. (2015) · arXiv (Cornell University) · doi:10.48550/arxiv.1502.02072 · Cited by 378
Self-citationHow good are predictions of protein secondary structure?
Kabsch, W., & Sander, C. (1983) · FEBS Letters · doi:10.1016/0014-5793(82)80597-8 · Cited by 372
In silico pharmacology for drug discovery: applications to targets and beyond
Ekins, S., Mestres, J., & Testa, B. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707306 · Cited by 365
Structure−Activity Landscape Index: Identifying and Quantifying Activity Cliffs
Guha, R., & Van Drie, J. H. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci7004093 · Cited by 360
Accurate calculation of the absolute free energy of binding for drug molecules
Aldeghi, M., Heifetz, A., Bodkin, M. J., Knapp, S., & Biggin, P. C. (2016) · Chemical Science · doi:10.1039/c5sc02678d · Cited by 347
Sastry, M., Lowrie, J. F., Dixon, S. L., & Sherman, W. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100062n · Cited by 332
Klebe, G., & Abraham, U. (1999) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008047919606 · Cited by 294
Ligand efficiency indices for effective drug discovery
Abad-Zapatero, C. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.4.469 · Cited by 279
Combination of ligand- and structure-based methods in virtual screening
Drwal, M. N., & Griffith, R. (2013) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2013.02.002 · Cited by 209
Crystal Structure of an Active Form of BACE1, an Enzyme Responsible for Amyloid β Protein Production
Shimizu, H., Tosaki, A., Kaneko, K., Hisano, T., Sakurai, T., & Nukina, N. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02185-07 · Cited by 205
In-Silico ADME Models: A General Assessment of their Utility in Drug Discovery Applications
Paul Gleeson, M., Hersey, A., & Hannongbua, S. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611794480927 · Cited by 196
Potential and Limitations of Ensemble Docking
Korb, O., Olsson, T. S. G., Bowden, S. J., Hall, R. J., Verdonk, M. L., Liebeschuetz, J. W., & Cole, J. C. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci2005934 · Cited by 169
Homeyer, N., Stoll, F., Hillisch, A., & Gohlke, H. (2014) · Journal of Chemical Theory and Computation · doi:10.1021/ct5000296 · Cited by 166
Understanding the Roles of the “Two QSARs”
Fujita, T., & Winkler, D. A. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00229 · Cited by 166
Craig, I. R., Essex, J. W., & Spiegel, K. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci900407c · Cited by 147
Ligand Binding Thermodynamics in Drug Discovery: Still a Hot Tip?
Geschwindner, S., Ulander, J., & Johansson, P. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501511f · Cited by 126
Comparative Analysis of Pharmacophore Screening Tools
Sanders, M. P. A., Barbosa, A. J. M., Zarzycka, B. A., Nicolaes, G. A. F., Klomp, J. P. G., de Vlieg, J., & Río, A. D. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci2005274 · Cited by 118
Xu, Y., Li, M., Greenblatt, H. M., Chen, W., Paz, A., Dym, O., Peleg, Y., Chen, T., Shen, X., He, J., et al. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444911047251 · Cited by 117
Abad‐Zapatero, C., Perišić, O., Wass, J. A. H., Bento, A. P., Overington, J. P., Al‐Lazikani, B., & Johnson, M. E. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.08.004 · Cited by 116
Application of Free Energy Perturbation for the Design of BACE1 Inhibitors
Ciordia, M., Pérez‐Benito, L., Delgado, F., Trabanco, A. A., & Tresadern, G. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00220 · Cited by 104
Progress in visual representations of chemical space
Osolodkin, D. I., Radchenko, E. V., Orlov, A. A., Voronkov, A. E., Palyulin, V. A., & Zefirov, N. S. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1060216 · Cited by 98
pH-Dependent Population Shift Regulates BACE1 Activity and Inhibition
Ellis, C. R., & Shen, J. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b05891 · Cited by 82
Kernel-Based Partial Least Squares: Application to Fingerprint-Based QSAR with Model Visualization
An, Y., Sherman, W., & Dixon, S. L. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400250c · Cited by 68
Sheridan, R. P. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00110 · Cited by 66
Peach, M. L., Zakharov, A. V., Liu, R., Pugliese, A., Tawa, G. J., Wallqvist, A., & Nicklaus, M. C. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.150 · Cited by 63
Mendenhall, J., & Meiler, J. (2016) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-016-9895-2 · Cited by 63
Effect of the Protonation State of the Titratable Residues on the Inhibitor Affinity to BACE-1
Domínguez, J. L., Christopeit, T., Villaverde, M. C., Gossas, T., Otero, J. M., Nyström, S., Baraznenok, V., Lindström, E., Danielson, U. H., & Sussman, F. (2010) · Biochemistry · doi:10.1021/bi100637n · Cited by 57
Exploring conformational search protocols for ligand-based virtual screening and 3-D QSAR modeling
Cappel, D., Dixon, S. L., Sherman, W., & Duan, J. (2014) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-014-9813-4 · Cited by 55
Best of Both Worlds: On the Complementarity of Ligand-Based and Structure-Based Virtual Screening
Broccatelli, F., & Brown, N. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci5001604 · Cited by 50
Huang, S., Li, M., Wang, J., & Pan, Y. F. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00275 · Cited by 42
Compound high-quality criteria: a new vision to guide the development of drugs, current situation
Mignani, S. M., Huber, S., Tomás, H., Rodrigues, J., & Majoral, J. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.005 · Cited by 39
Template CoMFA: The 3D-QSAR Grail?
CRAMER, R. D. I., & Wendt, B. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci400696v · Cited by 35
Binding Mode and Induced Fit Predictions for Prospective Computational Drug Design
Grebner, C., Iegre, J., Ulander, J., Edman, K., Hogner, A., & Tyrchan, C. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00744 · Cited by 33
A comprehensive company database analysis of biological assay variability
Krämer, C., Dahl, G., Tyrchan, C., & Ulander, J. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.03.015 · Cited by 31
High-resolution crystal structures leverage protein binding affinity predictions
Marillet, S., Boudinot, P., & Cazals, F. (2015) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24946 · Cited by 29
Advances in quantitative structure–activity relationship models of anti-Alzheimer’s agents
Ambure, P. S., & Roy, K. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.909404 · Cited by 24
Manoharan, P., Chennoju, K., & Ghoshal, N. (2015) · Molecular BioSystems · doi:10.1039/c5mb00088b · Cited by 19
X-ray Crystallographic Structures as a Source of Ligand Alignment in 3D-QSAR
Urniaż, R., & Jóźwiak, K. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400004e · Cited by 18
CRAMER, R. D. I. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129307 · Cited by 14
Pharmacophore Identification and Pseudo-Receptor Modeling
Wolber, G., & Sippl, W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417205-0.00021-3 · Cited by 14
Integration of Ligand and Structure Based Approaches for CSAR-2014
Prathipati, P., & Mizuguchi, K. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00477 · Cited by 14
Interaction mechanism exploration of HEA derivatives as BACE1 inhibitors by in silico analysis
Wu, Q., Li, X., Qingping, G., Wang, J., Li, Y., & Yang, L. (2016) · Molecular BioSystems · doi:10.1039/c5mb00859j · Cited by 10
Template CoMFA Applied to 116 Biological Targets
CRAMER, R. D. I. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500230a · Cited by 8
Cited by
MoleculeNet: a benchmark for molecular machine learning
Wu, Z., Ramsundar, B., Feinberg, E. N., Gomes, J., Geniesse, C., Pappu, A. S., Leswing, K., & Pande, V. (2018) · Chemical Science · doi:10.1039/c7sc02664a · Cited by 3,107
Self-citationOpportunities and obstacles for deep learning in biology and medicine
Ching, T., Himmelstein, D. S., Beaulieu-Jones, B. K., Kalinin, A. A., Do, B. T., Way, G. P., Ferrero, E., Agapow, P.-M., Zietz, M., Hoffman, M. M., et al. (2018) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0387 · Cited by 2,310
The rise of deep learning in drug discovery
Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.039 · Cited by 1,770
Shen, C. (2018) · Water Resources Research · doi:10.1029/2018wr022643 · Cited by 1,133
Low Data Drug Discovery with One-Shot Learning
Altae-Tran, H., Ramsundar, B., Pappu, A. S., & Pande, V. (2017) · ACS Central Science · doi:10.1021/acscentsci.6b00367 · Cited by 799
Self-citation
Metadata
- Authors
- Subramanian, G., Ramsundar, B., Pande, V., & Denny, R. A.
- Venue
- Journal of Chemical Information and Modeling
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-10-10
- Volume
- 56
- Issue
- 10
- Pages
- 1936-1949
- ISSN
- 1549-9596 (ISSN-L)
- 1549-960X
- OpenAlex
- W2461470610
- Cited by
- 285
- References
- 71
- FWCI
- 11.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.